Revisiting treatment paradigms in high-risk smoldering multiple myeloma: out with the old, in with the new?
Leuk Lymphoma
.
2013 Oct;54(10):2328-30.
doi: 10.3109/10428194.2013.788699.
Epub 2013 May 2.
Author
Irene M Ghobrial
1
Affiliation
1
Dana-Farber Cancer Institute , Boston, MA , USA.
PMID:
23540345
DOI:
10.3109/10428194.2013.788699
No abstract available
Publication types
Letter
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Multiple Myeloma / drug therapy*
Multiple Myeloma / mortality
Treatment Outcome